Meeting the EPS estimate and exceeding sales forecasts, especially with a notable year-over-year growth, is likely to be viewed positively by investors. This performance indicates solid financial health and operational efficiency, which could lead to increased investor confidence and potentially a positive short-term impact on PCRX's stock price.